Strengthening Safety, Reliability and Quality Systems
First written in FY2016. 11 of 17 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Number of serious observations by regulatory authorities 0 0 Serious market shortages 0 0」
For FY2025, there were 0 serious observations by regulatory authorities and 0 serious market shortages. On a disclosure basis, this represents a reduction from the 1 serious market shortage disclosed for the previous fiscal year. - FY2025Occurrence of serious market shortagesAnnual report
「Serious market shortages 0 1」
While there were 0 serious observations by regulatory authorities concerning quality and safety, the company disclosed 1 serious market shortage in FY2024. - FY2024AdvancedAnnual report
「Ensuring the quality and safety of products and services and a stable supply Number of serious observations by regulatory authorities 0 0 Serious market shortages 0 0」
For quality, safety and stable supply, the company disclosed 0 serious observations by regulatory authorities and 0 serious market shortages in FY2023. - FY2022RestatedAnnual report
「We believe that our most important social responsibility is to provide superior products and services consistently and with high quality, while taking the perspectives of patients and healthcare professionals and pursuing innovation to address the various social issues surrounding healthcare.」
The company continues to expressly identify high quality, stable supply, and the provision of safety and security as social responsibilities. - FY2020AdvancedAnnual report
「To build a sustainable value chain capable of consistently supplying high-quality products to healthcare settings, the company has developed a business continuity plan (BCP) for materials procurement and is working to strengthen initiatives related to quality control, compliance and EHS (environmental, health and safety), including by establishing cooperative arrangements with suppliers.」
The policy on safety, security and quality systems was put into practice through a BCP for materials procurement, cooperation with suppliers, global quality governance and site reviews through internal audits. - FY2020-Q3RestatedAnnual report
「We believe that our most important social responsibility is to provide excellent products, services, and systems consistently and at a high level of quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare.」
The company continues to identify the provision of high-quality products and a stable supply, and addressing social issues from the perspectives of patients and healthcare professionals, as social responsibilities. - FY2020-Q2RestatedAnnual report
「We believe that our most important social responsibility is to provide excellent products, services, and systems consistently and at a high level of quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare.」
The company continues to identify the provision of high-quality products and a stable supply, and addressing social issues from the perspectives of patients and healthcare professionals, as social responsibilities. - FY2019RestatedAnnual report
「We believe that our most important social responsibility is to provide excellent products, services, and systems consistently and at a high level of quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare.」
The company continues to identify the provision of high-quality products and a stable supply, and addressing social issues from the perspectives of patients and healthcare professionals, as social responsibilities. - FY2019-Q3RestatedAnnual report
「We believe that our most important social responsibility is to provide superior products, services and systems consistently and with high quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare. Based on this approach, the company will continue to play an important role in the global healthcare supply system by ensuring product supply and quality, and will provide safety and security in healthcare settings.」
The company continues to present high-quality, reliable supply and its commitment to addressing social issues from the perspectives of patients and healthcare professionals as its social responsibility. - FY2019-Q2RestatedAnnual report
「We believe that our most important social responsibility is to provide superior products, services and systems consistently and with high quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare. Based on this approach, the company will continue to play an important role in the global healthcare supply system by ensuring product supply and quality, and will provide safety and security in healthcare settings.」
The company continues to present high-quality, reliable supply and its commitment to addressing social issues from the perspectives of patients and healthcare professionals as its social responsibility. - FY2018-Q3RestatedAnnual report
「We believe that our most important social responsibility is to provide superior products, services and systems consistently and with high quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare. Based on this approach, the company will continue to play an important role in the global healthcare supply system by ensuring product supply and quality, and will provide safety and security in healthcare settings.」
The company continues to present high-quality, reliable supply and its commitment to addressing social issues from the perspectives of patients and healthcare professionals as its social responsibility. - FY2018-Q2RestatedAnnual report
「Based on this approach, the company will continue to play an important role in the global healthcare supply system by ensuring product supply and quality, and will provide safety and security in healthcare settings.」
The company continues to state its policy of providing safety and security in healthcare settings through a stable supply of products and quality assurance. - FY2018-Q1RestatedAnnual report
「Based on this approach, the company will continue to play an important role in the global healthcare supply system by ensuring product supply and quality, and will provide safety and security in healthcare settings.」
The company continues to state its policy of providing safety and security in healthcare settings through a stable supply of products and quality assurance. - FY2017-Q3RestatedAnnual report
「Based on this approach, the company will continue to play an important role in the global healthcare supply system by ensuring product supply and quality, and will provide safety and security in healthcare settings.」
The company continues to state its policy of providing safety and security in healthcare settings through product supply and quality assurance. - FY2017-Q2RestatedAnnual report
「We believe that our most important social responsibility is to provide excellent products, services, and systems consistently and at a high level of quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare.」
The company continues to identify the provision of high-quality products and a stable supply, as well as addressing social issues from the perspectives of patients and healthcare professionals, as social responsibilities. - FY2017-Q1AdvancedAnnual report
「In the CV business, an inspection by the U.S. Food and Drug Administration (FDA) at the Ann Arbor plant of the U.S. subsidiary Terumo Cardiovascular Systems, Inc. was completed with no observations, and all sales restrictions were lifted in June.」
There was concrete progress in quality and regulatory compliance, with the FDA inspection completed without observations and all sales restrictions lifted. - FY2016First statedAnnual report
「We believe that our most important social responsibility is to provide excellent products, services, and systems consistently and at a high level of quality, while taking the perspectives of patients and healthcare professionals and actively addressing the various social issues surrounding healthcare.」
The company positions quality and stable supply as social responsibilities and manufactures products in accordance with its quality management system and GMP standards.